Dr Peter Yellowlees discusses 1-year symptom trajectories in patients with stable schizophrenia maintained on antipsychotics versus placebo.

A book offering clinical assessments of President Trump's mental health has become a best seller. It's also a threat to psychiatry's reputation, says Dr Jeffrey Lieberman.

Benzodiazepines could increase mortality rates, especially in the elderly, but the latest research might suggest otherwise.

A Cochrane methodology study revealed some positive effects of a classic Chinese herbal therapy when combined with antipsychotics.

Dr Jeffrey Lieberman scrutinizes the current trend of repurposing 'feel good' drugs for serious mental conditions.

Dr Jack Drescher urges healthcare professionals to review and revise basic paperwork and urge staff to recognize the unique challenges of patients struggling with sex and gender identity challenges.

After receiving a solicitation from a ketamine clinic, Dr Jeffrey Lieberman did some digging. What he found troubled him.

Gender dysphoria was first described in the late 1800s, but the concept didn't enter the popular imagination until the 1950s.

Changes in the DSM-5 and ICD-11 are meant to improve accuracy and reduce stigma but retain access to care, says Dr Jack Drescher.

Dr Diener reviews five studies that run the gamut of neurology--from anticoagulant reversal, MS, and carotid stenosis, to temporal arteritis and complications of long-term opioid use.